Nutriband Inc. (NTRB)
NASDAQ: NTRB · Real-Time Price · USD
5.78
-0.35 (-5.71%)
At close: Apr 1, 2025, 4:00 PM
5.80
+0.02 (0.35%)
After-hours: Apr 1, 2025, 4:05 PM EDT
Nutriband Employees
Nutriband had 13 employees as of January 31, 2022. The number of employees increased by 8 or 160.00% compared to the previous year.
Employees
13
Change (1Y)
8
Growth (1Y)
160.00%
Revenue / Employee
$155,521
Profits / Employee
-$526,703
Market Cap
64.19M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NTRB News
- 5 weeks ago - Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development. - GlobeNewsWire
- 6 weeks ago - Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch - GlobeNewsWire
- 7 weeks ago - Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™ - GlobeNewsWire
- 3 months ago - Nutriband Issues Letter to Shareholders - GlobeNewsWire
- 3 months ago - Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology - GlobeNewsWire
- 4 months ago - Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - GlobeNewsWire
- 4 months ago - Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology - GlobeNewsWire
- 5 months ago - Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application - Accesswire